---
figid: PMC4588730__zmg9991555930002
figlink: /pmc/articles/PMC4588730/figure/F2/
number: Figure 2
caption: The functions of FGF19 and the corresponding mechanisms. Endogenous FGF19
  expression is induced in intestinal enterocytes by the activation of FXR/RXR heterodimers.
  Secreted FGF19 mediates multiple metabolic processes. On one hand, FGF19 can bind
  to FGFR4 in the presence of β-Klotho and activation of cAMP, followed by stimulation
  of bile acid filling into the gallbladder. In addition, liver is another key target
  organ of FGF19 that activates the SHP/CYP7A1 pathway by binding with FGFR4/β-Klotho
  that negatively regulates bile acid synthesis. On the other hand, by binding with
  FGFR1/β-Klotho, FGF19 mainly regulates glucose metabolism, including suppression
  of gluconeogenesis and enhancement of glucose catabolism via the inhibition of the
  CREB/PGC-1α pathway, and improvement of glycogen synthesis via inhibition of GS
  kinase (GSK) pathway. CYP7A1, cholesterol 7-a-monooxygenase; FXR, farnesoid X receptor;
  GSK3, GS kinase-3; RXR, retinoid X receptor; SHP, protein tyrosine phosphatase.
pmcid: PMC4588730
papertitle: 'Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic
  Regulation and Chronic Diseases.'
reftext: Fangfang Zhang, et al. Mol Endocrinol. 2015 Oct;29(10):1400-1413.
pmc_ranked_result_index: '13758'
pathway_score: 0.9458808
filename: zmg9991555930002.jpg
figtitle: Functions of FGF19 and the corresponding mechanisms
year: '2015'
organisms: Homo sapiens
ndex: 5cce2523-defc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4588730__zmg9991555930002.html
  '@type': Dataset
  description: The functions of FGF19 and the corresponding mechanisms. Endogenous
    FGF19 expression is induced in intestinal enterocytes by the activation of FXR/RXR
    heterodimers. Secreted FGF19 mediates multiple metabolic processes. On one hand,
    FGF19 can bind to FGFR4 in the presence of β-Klotho and activation of cAMP, followed
    by stimulation of bile acid filling into the gallbladder. In addition, liver is
    another key target organ of FGF19 that activates the SHP/CYP7A1 pathway by binding
    with FGFR4/β-Klotho that negatively regulates bile acid synthesis. On the other
    hand, by binding with FGFR1/β-Klotho, FGF19 mainly regulates glucose metabolism,
    including suppression of gluconeogenesis and enhancement of glucose catabolism
    via the inhibition of the CREB/PGC-1α pathway, and improvement of glycogen synthesis
    via inhibition of GS kinase (GSK) pathway. CYP7A1, cholesterol 7-a-monooxygenase;
    FXR, farnesoid X receptor; GSK3, GS kinase-3; RXR, retinoid X receptor; SHP, protein
    tyrosine phosphatase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3L1
  - CREB3L3
  - MAPK1
  - FGF19
  - FGFR4
  - CREB3
  - CREM
  - RXRG
  - CREB3L2
  - ATF2
  - MAPK3
  - CREB3L4
  - GNAL
  - CREB5
  - NR1H4
  - RXRA
  - FGFR1
  - ATF1
  - RXRB
  - GNAS
  - CREB1
  - Bile acid
  - Glucose
genes:
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: FGF19
  symbol: FGF19
  source: hgnc_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGFR4/B-Klotho
  symbol: FGFR4
  source: hgnc_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: FXR/RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRG
  entrez: '6258'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: GS
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: FXR/RXR
  symbol: FXR
  source: hgnc_alias_symbol
  hgnc_symbol: NR1H4
  entrez: '9971'
- word: FXR/RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRA
  entrez: '6256'
- word: FGFR1/B-Klotho
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: FXR/RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRB
  entrez: '6257'
- word: GS
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: CREB/PGC1-al
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
chemicals:
- word: Bile acid
  source: MESH
  identifier: D001647
- word: Glucose
  source: MESH
  identifier: D005947
diseases: []
---
